Circle 33, LLC
Records under this name other than the patents Circle 33, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Circle 33, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,435,526 | Methods of treating mucositis using anti-TNF antibodies Lapsed on the fee record Ended May 7, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 7, 2025 | From the USPTO record |
| US 8,268,971 | Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity Lapsed on the fee record Ended Sep 18, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2024 | From the USPTO record |
| US 8,182,818 | Methods of using anti-TNF antibodies for treating radiation damage to the digestive tract Lapsed on the fee record Ended May 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2024 | From the USPTO record |
| US 9,079,955 | Compositions comprising TNF-specific antibodies for oral delivery and methods of use thereof to treat inflammatory bowel disease Lapsed on the fee record Ended Jul 14, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2023 | From the USPTO record |
| US 8,592,560 | Antibodies to apical intestinal receptors and methods of treating metabolic disease Lapsed on the fee record Ended Nov 26, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 26, 2021 | From the USPTO record |
| US 8,728,471 | Antibody therapy for treatment of diseases associated with gluten intolerance Lapsed on the fee record Ended May 20, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 20, 2018 | From the USPTO record |
| US 8,647,626 | Compositions comprising TNF-specific antibodies for oral delivery Lapsed on the fee record Ended Feb 11, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 11, 2018 | From the USPTO record |
| US 8,071,101 | Antibody therapy for treatment of diseases associated with gluten intolerance Lapsed on the fee record Ended Dec 6, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 6, 2015 | From the USPTO record |